GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists
mayo 26, 2023
COPD is the elephant in the room for many patients with CVDs.
COPD is the elephant in the room for many patients with CVDs.
Cluster analyses in NOVELTY patients with asthma and/or COPD yielded identifiable clusters, with several discriminatory features that differed from conventional diagnostic characteristics.
Chronic Obstructive Pulmonary Disease (COPD) is the third cause of death worldwide. While tobacco smoking is a key risk factor, COPD also occurs in never-smokers (NS).
Alvar Agustí forma parte de la ACADEMIA EUROPAEA desde 2022 por sus numerosas aportaciones en contenido y publicaciones.
El 21 de junio se celebrará en CaixaFòrum Barcelona las XXXV Jornadas Técnicas del Institut Guttmann. Este año las jornadas están dedicadas a la humanización en la asistencia, con el foco en la neurorrehabilitación
1 year after an acute COVID-19 episode, patients with either lung sequelae or long COVID show a stronger SARS-CoV-2-specific T-cell response than fully recovered individuals, suggesting persistent cell stimulation by residual viral reservoirs
Chief Editor James Chalmers interviews Alvar Agusti (Hospital Clinic, Barcelona, Spain)about the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) report. Listen it here.
Los próximos 3, 4 y 5 de mayo tendrán lugar el VII Simposium Internacional de la EPOC y Tabaco y el XVII Simposium Internacional sobre prevención y tratamiento del tabaquismo.
«Chronic airway diseases such as asthma and chronic obstructive pulmonary disease are prevalent and complex conditions that often coexist in the same patient. To address this complexity in clinical practice, and to move forward toward personalized and precision…»
El pasado mes de febrero la UB celebró en su sala Paraninfo La “Barcelona Boston Lung Conference”, un foro anual de debate científico al más alto nivel sobre diversos aspectos de las enfermedades respiratorias, con un elenco de ponentes del máximo nivel internacional.